Skip to content

Clinical Trail on Tablet Vatagajankush Ras along with Anutail Nasal drops in Cervical Spondylosis

A Randamized control trail on Vatagajankush Ras along with Anutail Nasya in Manyagraha with special reference to Cervical Spondylosis - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/057137
Enrollment
180
Registered
2023-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M190- Primary osteoarthritis of other joints

Interventions

None listed

Sponsors

Dr Prerna R Masatkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having sign and symptoms of Manyagraha according to classics. 2. Neck pain more than three month. 3. The Oswestry neck disability questionnaire, which has been described in criteria of assessment will be taken in to account. 4. Patient willing and able to participate in the study. 5. Radiological changes, degenerative changes in cervical spine.

Exclusion criteria

Exclusion criteria: 1.History of any fracture of vertebral joint/ surgical/ diagnostic intervention with reference to affected joints will be excluded. 2.The patient who had fix joint or having developed contracture not be included in study. 3. Patient with uncontrolled hypertension (=160/100mm of Hg) and uncontrolled diabetes (Blood sugar level fasting >150mg/dl and post prandial >250mg/dl) will be ruled out. 4.Patient who are not fit for Nasya. 5. Patient with evidence of malignancy. 6. Patient on prolonged (=6weeks) medication with corticosteroids, nonsteroidal anti inflammatory drug, antidepressants, anticholinergic etc. or any drugs that may influence on the outcome of the study. 7. Patient who have a past history of any other systemic disorders will be excluded. 8. Pregnant / lactating women. 9.Patients who had participated in any other clinical trial since last six month.

Design outcomes

Primary

MeasureTime frame
To compare the effect of therapy in terms of improvement in (A) range of motion measured by goniometer (B) Oeswestry neck disability score. Timepoint: 21 days

Secondary

MeasureTime frame
To compare the effect of treatment in terms of symptomatic relief in all the three groups Timepoint: 1 week,2nd week,3rd week

Countries

India

Contacts

Public ContactDr Prerna R Masatkar

Prof.and HOD

dr.dachewar@gmail.com9834707734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026